Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
2.

Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers.

Hamidi A, Kreeftenberg H.

Hum Vaccin Immunother. 2014;10(9):2697-703. doi: 10.4161/hv.29300. Epub 2014 Nov 13.

3.
4.

Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.

Gupta RK, Anderson R, Cecchini D, Rost B, Griffin P Jr, Benscoter K, Xu J, Montanez-Ortiz L, Siber GR.

Dev Biol Stand. 1996;86:283-96.

PMID:
8785957
5.

Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.

Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, Boutriau D; HibMenCY-TT 005 Study Group.

Pediatr Infect Dis J. 2010 Jan;29(1):48-52. doi: 10.1097/INF.0b013e3181c3ce88.

PMID:
20035207
7.
8.
9.

Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.

Rana R, Dalal J, Singh D, Kumar N, Hanif S, Joshi N, Chhikara MK.

Vaccine. 2015 May 28;33(23):2646-54. doi: 10.1016/j.vaccine.2015.04.031. Epub 2015 Apr 20.

PMID:
25907408
11.
13.
14.
15.

Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis serogroup C diseases.

Saydam M, Burkin K, Care R, Rigsby P, Bolgiano B, Mawas F.

Vaccine. 2010 Aug 31;28(38):6228-34. doi: 10.1016/j.vaccine.2010.07.005. Epub 2010 Jul 16.

PMID:
20638457
16.

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

Zepp F, Schmitt HJ, Kaufhold A, Schuind A, Knuf M, Habermehl P, Meyer C, Bogaerts H, Slaoui M, Clemens R.

Eur J Pediatr. 1997 Jan;156(1):18-24.

PMID:
9007484
17.

Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants.

Kim KH, Lee H, Chung EH, Kang JH, Kim JH, Kim JS, Lee HJ, Oh SH, Park EA, Park SE.

J Korean Med Sci. 2008 Dec;23(6):929-36. doi: 10.3346/jkms.2008.23.6.929. Epub 2008 Dec 23.

18.

Safety and immunogenicity of an indigenously developed Haemophilus influenzae type b conjugate vaccine through various phases of clinical trials.

Sharma HJ, Multani AS, Dutta AK, Joshi SM, Malik S, Bhardwaj S, Chakravarty A, Namjoshi GS, Parekh S, Verma V.

Hum Vaccin. 2009 Jul;5(7):483-7. Epub 2009 Jul 31.

PMID:
19395868
Items per page

Supplemental Content

Write to the Help Desk